Lycia Therapeutics, Inc.

CIK 1806540 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for Lycia Therapeutics, Inc..

Recent SEC filings

FiledFormAccession number
Jun 25, 2026D0001806540-26-000001
May 23, 2024D0001806540-24-000002
Sep 16, 2021D0001806540-21-000003
Mar 17, 2020D0001806540-20-000001